New Zealand announced a ban on new prescriptions of puberty-blocking drugs for young transgender people, a move reflecting a growing global debate over access to gender-affirming healthcare. Health officials cited concerns over adolescents seeking transition, while current users will not be affected. Critics warned that this restriction could severely worsen the mental health and well-being of trans and gender-diverse youth. They argue that treatment decisions should remain with doctors, parents, and young people.
November 19, 2025 theguardian.com